Catalyst Pharmaceuticals (NASDAQ:CPRX) will release its quarterly earnings report on Wednesday, 2024-11-06. Here’s a brief overview for investors ahead of the announcement. Analysts anticipate Catalyst Pharmaceuticals to report an earnings per share (EPS) of $0.30. Anticipation surrounds Catalyst Pharmaceuticals’s announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter. New investors should understand that while earnings performance is important, market reactions are often driven by guidance. Earnings History SnapshotDuri…